RISK FACTORS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA

被引：0
|
作者：
Baurmann, H. [1 ]
Collenbusch, F. [1 ]
Schmid, C. [2 ]
Finke, J. [3 ]
Stadler, M. [4 ]
Borubaeuser, M. [5 ]
Schleuning, M. [1 ]
Schwerdtfeger, R. [1 ]
机构：
[1] Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany
[2] Univ Munich, Munich, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Leibniz Univ Hannover, Hannover, Germany
[5] Univ Dresden, Dresden, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2008年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2007.12.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] Reduced Intensity Allogeneic Stem Cell Transplantation for Younger Patients with Myelofibrosis
    Mannina, Daniele
    Wolschke, Christine
    Zabelina, Tatjana
    Zeck, Gaby
    von Pein, Ute-Marie
    Ayuk, Francis Ayuketang
    Kroeger, Nicolaus
    BLOOD, 2018, 132
  • [42] Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis
    Deeg, HJ
    Guardiola, P
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 29 - 34
  • [43] Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis
    Mannina, Daniele
    Wolschke, Christine
    Zabelina, Tatjana
    Zeck, Gaby
    von Pein, Ute-Marie
    Ayuk, Francis
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2019, 54 : 198 - 199
  • [44] Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis
    Mannina, Daniele
    Zabelina, Tatjana
    Wolschke, Christine
    Heinzelmann, Marion
    Triviai, Ioanna
    Christopeit, Maximilian
    Badbaran, Anita
    Bonmann, Stefan
    von Pein, Ute-Marie
    Janson, Dietlinde
    Ayuk, Francis
    Kroeger, Nicolaus
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (03) : 484 - 489
  • [45] QUALITY OF LIFE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS
    Machate, N.
    Alchalby, H.
    Zabelina, T.
    Wulf, G.
    Sehner, S.
    Wolff, D.
    Kobbe, G.
    Bornhaeuser, M.
    Baurmann, H.
    Bethge, W.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S31 - S32
  • [46] Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation
    Mannina, Daniele
    Gagelmann, Nico
    Badbaran, Anita
    Ditschkowski, Markus
    Bogdanov, Rashit
    Robin, Marie
    Cassinat, Bruno
    Heuser, Michael
    Shahswar, Rabia
    Thol, Felicitas
    Beelen, Dietrich
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (06) : 552 - 557
  • [47] The outcome of allogeneic hematopoietic stem cell transplantation for patients with primary myelofibrosis
    Sun, K.
    Tsai, X. C. -H.
    Liu, J. -H.
    Hsu, S. -C.
    Chou, W. -C.
    Liao, X. -W.
    Hou, H. -A.
    Ko, B. -S.
    Tien, H. -F.
    Tang, J. -L.
    Yao, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 161 - 161
  • [48] Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis
    H. Joachim Deeg
    Philippe Guardiola
    International Journal of Hematology, 2002, 76 : 29 - 34
  • [49] Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years
    Daghia, Giulia
    Zabelina, Tatjana
    Zeck, Gaby
    von Pein, Ute-Marie
    Christopeit, Maximilian
    Wolschke, Christine
    Ayuk, Francis
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 370 - 378
  • [50] Extramedullary Leukemia Relapse In Patients With Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation: Risk Factors and Prognosis
    Gupta, Vinay
    Gundabolu, Krishna
    Gonsalves, Wilson I.
    Litzow, Mark R.
    Hogan, William J.
    Gangat, Naseema
    Patnaik, Mrinal M.
    BLOOD, 2013, 122 (21)
12345